Todd Chappell Appointed CEO of Rasio Therapeutics

Published on :

Todd Chappell  Appointed CEO of Rasio Therapeutics Chappell is a 20-year veteran of the biopharma industry with experience running multiple drug development programs from the discovery stage through to clinical trials November 14, 2019, Baltimore, MD – Rasio Therapeutics, Inc., a biopharmaceutical company that develops novel medicines using cutting-edge computer-aided drug design technology, today announced the appointment of Todd Chappell, a veteran medtech and [….]

Emergent BioSolutions Welcomes Syed T. Husain as their New Senior Vice President, CDMO Business Unit Head

Published on :

Emergent BioSolutions Welcomes Syed T. Husain as their New Senior Vice President, CDMO Business Unit Head Mr. Husain joined Emergent in September 2019 and serves as the head of the contract development and manufacturing (CDMO) business unit. He most recently served as chief commercial officer at Alcami Corporation. Prior to that, he was head of [….]

Immunomic Therapeutics Appoints Harvard’s Brain Tumor Expert, Dr. E. Antonio Chiocca, to its Scientific Advisory Board

Published on :

Immunomic Therapeutics Appoints Harvard’s Brain Tumor Expert, Dr. E. Antonio Chiocca, to its Scientific Advisory Board ROCKVILLE, Md.–(BUSINESS WIRE)– Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that it has appointed brain tumor expert E. Antonio ‘Nino’ Chiocca, M.D., Ph.D., Harvey W. Cushing Professor of Neurosurgery, Harvard Medical School Neurosurgeon-in-Chief and [….]

CRB Welcomes Jacob Greenwood as Director of Business Development

Published on :

CRB Welcomes Jacob Greenwood as Director of Business Development Rockville, MD – September 3, 2019 – CRB is excited to welcome Jacob Greenwood as Director of Business Development in the Maryland office. Greenwood has twelve years’ experience in the biotechnology field, as well as a background in marketing and sales, technical services, and facility/program management.  [….]

Vaccitech Appoints Bill Enright as New Chief Executive Officer

Published on :

Vaccitech Appoints Bill Enright as New Chief Executive Officer OXFORD, UK, August 27, 2019 / B3C newswire / — Vaccitech, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases (ID), announced today that it has appointed Bill Enright as its new Chief Executive Officer (CEO). Mr. Enright succeeds Tom [….]

Ceres Nanosciences, Inc. announces New Head of Sales

Published on :

Ceres Nanosciences, Inc. announces New Head of Sales Ceres is very excited to announce that Tara Jones-Roe has joined Ceres as the head of sales. She comes to Ceres with nearly 20 years of experience in the diagnostics and life sciences industry at Molecular Devices, Beckman Coulter, Thermo Fisher Scientific, and Roche Diagnostics. Tara brings [….]

FACILITY LOGIX WELCOMES TWO NEW ASSOCIATE PROJECT MANAGERS TO BOLSTER PROJECT TEAMS

Published on :

Facility Logix Welcomes Two New Associate Project Managers to Bolster Project Teams Burtonsville, MD – August 1, 2019 – Facility Logix, a leading life science consulting firm, has hired two new Associate Project Managers:  Jocaro L. Dodd and Wayne Mitchell.  The new Associate Project Managers will be instrumental in addressing the facility-related needs of the firm’s [….]

CRB Announces the Promotion of Ben Skowronski to the Leader of the Maryland office

Published on :

CRB Announces the Promotion of Ben Skowronski to the Leader of the Maryland office CRB is excited to announce the promotion of Ben Skowronski to the leader of the Maryland office. Skowronski has demonstrated strong leadership and business development skills in the architecture, engineering and construction industries in the Northeast for 15 years and has [….]

MaxCyte Adds Vice President, Non-Clinical and Translational Studies, to Support Advancement of Programs from Its CARMA™ Platform

Dhana Chinnasamy, PhD
Published on :

MaxCyte Adds Vice President, Non-Clinical and Translational Studies, to Support Advancement of Programs from Its CARMA™ Platform Dhana Chinnasamy, PhD, will oversee non-clinical and translational activities for MaxCyte’s autologous cell therapy platform for targeted cell-based immune therapies GAITHERSBURG, Md., July 23, 2019 /PRNewswire/ — MaxCyte, the global clinical-stage cell-based therapies and life sciences company, announced today that it [….]